Sign Up to like & get
recommendations!
1
Published in 2018 at "International Psychogeriatrics"
DOI: 10.1017/s104161021800011x
Abstract: ABSTRACT Background: The use of FDA approved medications for Alzheimer's disease [AD; FDAAMAD; (cholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists)] has been associated with symptomatic benefit with a reduction in formal (paid services) and total costs…
read more here.
Keywords:
use fda;
approved medications;
informal costs;
medications alzheimer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2018.1411478
Abstract: ABSTRACT Introduction: Atopic dermatitis (AD) is a common disease in children and adults which causes severe physical discomfort and psychosocial distress. Recently novel therapies for AD have been FDA approved for use which creates the…
read more here.
Keywords:
atopic dermatitis;
fda approved;
approved medications;
safety ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of child and adolescent psychopharmacology"
DOI: 10.1089/cap.2021.0027
Abstract: Objectives: The decision to prescribe a medication and the choice of which one are often complex, particularly in the field of child and adolescent psychiatry where evidence is scarce. The aim of this review is…
read more here.
Keywords:
child adolescent;
countries united;
approved medications;
children adolescents ... See more keywords